219 related articles for article (PubMed ID: 22039883)
61. Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.
Boyd KE; Xiao YY; Fan K; Poholek A; Copeland NG; Jenkins NA; Perkins AS
Blood; 2006 Jan; 107(2):733-41. PubMed ID: 16204320
[TBL] [Abstract][Full Text] [Related]
62. A novel EVI1 gene family, MEL1, lacking a PR domain (MEL1S) is expressed mainly in t(1;3)(p36;q21)-positive AML and blocks G-CSF-induced myeloid differentiation.
Nishikata I; Sasaki H; Iga M; Tateno Y; Imayoshi S; Asou N; Nakamura T; Morishita K
Blood; 2003 Nov; 102(9):3323-32. PubMed ID: 12816872
[TBL] [Abstract][Full Text] [Related]
63. The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions.
Wieser R
Gene; 2007 Jul; 396(2):346-57. PubMed ID: 17507183
[TBL] [Abstract][Full Text] [Related]
64. Evi-1 transforming and repressor activities are mediated by CtBP co-repressor proteins.
Palmer S; Brouillet JP; Kilbey A; Fulton R; Walker M; Crossley M; Bartholomew C
J Biol Chem; 2001 Jul; 276(28):25834-40. PubMed ID: 11328817
[TBL] [Abstract][Full Text] [Related]
65. Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset.
Otsuki M; Fukuda N; Inoue T; Mineshige T; Otsuki T; Horikoshi S; Endo M; Abe M
Molecules; 2019 Sep; 24(17):. PubMed ID: 31480595
[TBL] [Abstract][Full Text] [Related]
66. Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.
Morishita K; Parganas E; William CL; Whittaker MH; Drabkin H; Oval J; Taetle R; Valentine MB; Ihle JN
Proc Natl Acad Sci U S A; 1992 May; 89(9):3937-41. PubMed ID: 1570317
[TBL] [Abstract][Full Text] [Related]
67. Design, synthesis, and DNA binding characteristics of a group of orthogonally positioned diamino, N-formamido, pyrrole- and imidazole-containing polyamides.
Chavda S; Babu B; Patil P; Plaunt A; Ferguson A; Lee M; Tzou S; Sjoholm R; Rice T; Mackay H; Ramos J; Wang S; Lin S; Kiakos K; Wilson WD; Hartley JA; Lee M
Bioorg Med Chem; 2013 Jul; 21(13):3907-18. PubMed ID: 23647824
[TBL] [Abstract][Full Text] [Related]
68. CML cells expressing the TEL/MDS1/EVI1 fusion are resistant to imatinib-induced apoptosis through inhibition of BAD, but are resensitized with ABT-737.
Shimada K; Tomita A; Minami Y; Abe A; Hind CK; Kiyoi H; Cragg MS; Naoe T
Exp Hematol; 2012 Sep; 40(9):724-737.e2. PubMed ID: 22634393
[TBL] [Abstract][Full Text] [Related]
69. Thrombopoietin/MPL signaling confers growth and survival capacity to CD41-positive cells in a mouse model of Evi1 leukemia.
Nishikawa S; Arai S; Masamoto Y; Kagoya Y; Toya T; Watanabe-Okochi N; Kurokawa M
Blood; 2014 Dec; 124(24):3587-96. PubMed ID: 25298035
[TBL] [Abstract][Full Text] [Related]
70. Design, synthesis and anti-cancer activity of pyrrole-imidazole polyamides through target-downregulation of c-kit gene expression.
Zhang M; Liang J; Jiang SK; Xu L; Wu YL; Awadasseid A; Zhao XY; Xiong XQ; Sugiyama H; Zhang W
Eur J Med Chem; 2020 Dec; 207():112704. PubMed ID: 32866755
[TBL] [Abstract][Full Text] [Related]
71. Acetylation of the proto-oncogene EVI1 abrogates Bcl-xL promoter binding and induces apoptosis.
Pradhan AK; Mohapatra AD; Nayak KB; Chakraborty S
PLoS One; 2011; 6(9):e25370. PubMed ID: 21980434
[TBL] [Abstract][Full Text] [Related]
72. Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells.
Du Y; Jenkins NA; Copeland NG
Blood; 2005 Dec; 106(12):3932-9. PubMed ID: 16109773
[TBL] [Abstract][Full Text] [Related]
73. Molecular Characteristics of DNA-Alkylating PI Polyamides Targeting RUNX Transcription Factors.
Maeda R; Sato S; Obata S; Ohno T; Hashiya K; Bando T; Sugiyama H
J Am Chem Soc; 2019 Mar; 141(10):4257-4263. PubMed ID: 30601664
[TBL] [Abstract][Full Text] [Related]
74. The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy.
Métais JY; Dunbar CE
Mol Ther; 2008 Mar; 16(3):439-49. PubMed ID: 18227842
[TBL] [Abstract][Full Text] [Related]
75. Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia.
Glass C; Wuertzer C; Cui X; Bi Y; Davuluri R; Xiao YY; Wilson M; Owens K; Zhang Y; Perkins A
PLoS One; 2013; 8(6):e67134. PubMed ID: 23826213
[TBL] [Abstract][Full Text] [Related]
76. Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements.
Sitailo S; Sood R; Barton K; Nucifora G
Leukemia; 1999 Nov; 13(11):1639-45. PubMed ID: 10557037
[TBL] [Abstract][Full Text] [Related]
77. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations.
Russell M; List A; Greenberg P; Woodward S; Glinsmann B; Parganas E; Ihle J; Taetle R
Blood; 1994 Aug; 84(4):1243-8. PubMed ID: 8049440
[TBL] [Abstract][Full Text] [Related]
78. Myeloid transforming protein Evi1 interacts with methyl-CpG binding domain protein 3 and inhibits in vitro histone deacetylation by Mbd3/Mi-2/NuRD.
Spensberger D; Vermeulen M; Le Guezennec X; Beekman R; van Hoven A; Bindels E; Stunnenberg H; Delwel R
Biochemistry; 2008 Jun; 47(24):6418-26. PubMed ID: 18500823
[TBL] [Abstract][Full Text] [Related]
79. Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide.
Wang X; Nagase H; Watanabe T; Nobusue H; Suzuki T; Asami Y; Shinojima Y; Kawashima H; Takagi K; Mishra R; Igarashi J; Kimura M; Takayama T; Fukuda N; Sugiyama H
Cancer Sci; 2010 Mar; 101(3):759-66. PubMed ID: 20085585
[TBL] [Abstract][Full Text] [Related]
80. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
